NCT04127721 2020-10-29Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantationM.D. Anderson Cancer CenterPhase 2 Withdrawn
NCT02355431 2019-03-08Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsIncyte CorporationPhase 2 Withdrawn